Yann Mazabraud - 14 Feb 2023 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
EVP, Head of International
Signature
/s/ Hunter Smith, Attorney-in-Fact for Yann Mazabraud
Issuer symbol
RYTM
Transactions as of
14 Feb 2023
Transactions value $
-$31,814
Form type
4
Filing time
16 Feb 2023, 15:05:40 UTC
Previous filing
14 Feb 2023
Next filing
18 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Sale -$31.8K -1.18K -23.52% $27.03 3.83K 14 Feb 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.